The efficacy and safety of irinotecan plus doxorubicin liposome in relapsed/refractory Wilms' tumors: A retrospective study.

被引：0
|
作者：
Wang, Juan [1 ]
Zhang, Lian [1 ]
Que, Yi [1 ]
Zhen, Zijun [1 ]
Zhu, Jia [1 ]
Sun, Feifei [1 ]
Lu, Suying [1 ]
Huang, Junting [1 ]
Wu, Liuhong [1 ]
Cai, Ruiqing [1 ]
Zhang, Yizhuo [1 ]
Sun, Xiaofei [1 ]
机构：
[1] Sun Yat Sen Univ, Canc Ctr, Guangzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.e22007
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e22007
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Irinotecan Plus Doxorubicin Hydrochloride Liposomes for Relapsed or Refractory Wilms Tumor
    Wang, Juan
    Zhang, Lian
    Guo, Lanying
    Que, Yi
    Zhang, Yu
    Sun, Feifei
    Zhu, Jia
    Lu, Suying
    Huang, Junting
    Wu, Liuhong
    Cai, Ruiqing
    Zhen, Zijun
    Zeng, Sihui
    Zhang, Yizhuo
    Sun, Xiaofei
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [2] Irinotecan plus temozolomide in refractory or relapsed pediatric solid tumors
    Hernandez-Marques, C.
    Lassaletta-Atienza, A.
    Ruiz Hernandez, A.
    Blumenfeld Olivares, J. A.
    Arce Abaitua, B.
    Cormenzana Carpio, M.
    Madero Lopez, L.
    ANALES DE PEDIATRIA, 2013, 79 (02): : 68 - 74
  • [3] The efficacy and safety of anlotinib in refractory/recurrent/advanced pediatric solid tumors: A retrospective study.
    Lu, Suying
    Hong, Ye
    Chen, Huimou
    Wu, Liuhong
    Zhu, Jia
    Wang, Juan
    Sun, Feifei
    Zhen, Zijun
    Que, Yi
    Zhang, Lian
    Sun, Xiaofei
    Huang, Junting
    Zhang, Yizhuo
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [4] The Efficacy and Safety of Irinotecan, Paclitaxel and Oxaliplatin (IPO) Regimen as Salvage in Relapsed/Refractory Ovarian Germ Cell Tumors
    Kesana, Sivasree
    Jayachandran, Perumal Kalaiyarasi
    Selvarajan, Gangothri
    Carthikeyan, Subramaniam Murali
    Radhakrishnan, Venkatraman
    Sagar, Tenali Gnana
    Ganesan, Trivadi Sundaram
    INDIAN JOURNAL OF GYNECOLOGIC ONCOLOGY, 2023, 21 (01)
  • [5] The Efficacy and Safety of Irinotecan, Paclitaxel and Oxaliplatin (IPO) Regimen as Salvage in Relapsed/Refractory Ovarian Germ Cell Tumors
    Sivasree Kesana
    Perumal Kalaiyarasi Jayachandran
    Gangothri Selvarajan
    Subramaniam Murali Carthikeyan
    Venkatraman Radhakrishnan
    Tenali Gnana Sagar
    Trivadi Sundaram Ganesan
    Indian Journal of Gynecologic Oncology, 2023, 21
  • [6] A retrospective study of efficacy and safety of mechlorethamine, vindesine, liposomal doxorubicin, and prednisone (MODP) in relapsed/refractory classical Hodgkin lymphoma.
    Zhou, Min-Hang
    Wang, Chunmeng
    Liu, Yang
    Ku, Wenjing
    Yang, Qingming
    Han, Weidong
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [7] The Efficacy and Safety of Irinotecan Plus Temozolomide and Vincristine in Neuroblastoma with Brain Recurrence: A Retrospective Study
    Wang, J.
    Zhen, Z.
    Zhu, S.
    Lian, Z.
    Lu, S.
    Sun, F.
    Huang, J.
    Zhang, Y.
    Sun, X.
    PEDIATRIC BLOOD & CANCER, 2021, 68 : S213 - S214
  • [8] EFFICACY AND SAFETY OF BORTEZOMIB PLUS DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA
    Sanchez, R. Garcia
    Saldana, R.
    Caparros, I.
    Gallardo, A.
    Garcia-Delgado, R.
    Rosell, A.
    Campos, A.
    de Llano, M. P. Queipo
    Perez, I.
    Moreno, M. J.
    Del Castillo, S.
    De la Torre, S.
    Ramirez, G.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 500 - 500
  • [9] Pegylated Liposomal Doxorubicin plus Bortezomib in Relapsed or Refractory Multiple Myeloma: Efficacy and Safety in Patients with Renal Function Impairment
    Blade, Joan
    Sonneveld, Pieter
    Miguel, Jesus E. San
    Sutherland, Heather J.
    Hajek, Roman
    Nagler, Arnon
    Spencer, Andrew
    Robak, Tadeusz
    Cibeira, M. Teresa
    Zhuang, Sen H.
    Harousseau, Jean-Luc
    Orlowski, Robert Z.
    CLINICAL LYMPHOMA & MYELOMA, 2008, 8 (06): : 352 - 355
  • [10] Combination of bevacizumab plus irinotecan in recurrent malignant gliomas (MG): A retrospective study of efficacy and safety
    Gil Gil, M. J., Sr.
    Martinez-Garcia, M.
    Reynes, G.
    Costas, E.
    Fernandez-Chacon, C.
    Pernas, S.
    Benavides, M.
    Herrero, A.
    Perez-Martin, J.
    Balana, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
12345